Last reviewed · How we verify

Birch pollen allergoid — Competitive Intelligence Brief

Birch pollen allergoid (Birch pollen allergoid) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Allergen immunotherapy (allergoid). Area: Immunology / Allergy.

phase 3 Allergen immunotherapy (allergoid) Birch pollen allergens (Bet v 1 and related epitopes) Immunology / Allergy Biologic Live · refreshed every 30 min

Target snapshot

Birch pollen allergoid (Birch pollen allergoid) — Allergopharma GmbH & Co. KG. Birch pollen allergoid is a modified birch pollen extract that induces immune tolerance to birch pollen allergens through gradual desensitization.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Birch pollen allergoid TARGET Birch pollen allergoid Allergopharma GmbH & Co. KG phase 3 Allergen immunotherapy (allergoid) Birch pollen allergens (Bet v 1 and related epitopes)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Allergen immunotherapy (allergoid) class)

  1. Allergopharma GmbH & Co. KG · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Birch pollen allergoid — Competitive Intelligence Brief. https://druglandscape.com/ci/birch-pollen-allergoid. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: